These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 24084318)

  • 41. The multiple facets of opioid receptor function: implications for addiction.
    Lutz PE; Kieffer BL
    Curr Opin Neurobiol; 2013 Aug; 23(4):473-9. PubMed ID: 23453713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cocaine withdrawal in Planaria.
    Raffa RB; Valdez JM
    Eur J Pharmacol; 2001 Oct; 430(1):143-5. PubMed ID: 11698074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Some psychological aspects of nicotinism.
    ARNTZEN FI
    Am J Psychol; 1948 Jul; 61(3):424. PubMed ID: 18874589
    [No Abstract]   [Full Text] [Related]  

  • 44. Schild Analysis of the Interaction between Parthenolide and Cocaine Suggests an Allosteric Relationship for Their Effects on Planarian Motility.
    Kakuturu J; O'Brien M; Pagán OR
    Biomolecules; 2024 Sep; 14(9):. PubMed ID: 39334934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of miRNA-144-3p/Oprk1/KOR in nicotine dependence and nicotine withdrawal in male rats.
    Shao J; Fei Y; Xiao J; Wang L; Zou S; Yang J
    Nicotine Tob Res; 2023 Nov; 25(12):1856-1864. PubMed ID: 37455648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Planarian nociception: Lessons from a scrunching flatworm.
    Reho G; Lelièvre V; Cadiou H
    Front Mol Neurosci; 2022; 15():935918. PubMed ID: 35959107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nicotine-induced C-shape movements in planarians are reduced by antinociceptive drugs: Implications for pain in planarian paroxysm etiology?
    Kim A; Rawls SM
    Brain Res; 2022 Mar; 1778():147770. PubMed ID: 34979130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating a school-based science program that teaches the physiological effects of nicotine.
    Cameron JL; Brasch K; Strong D; Paul B; Cavanaugh E; Thakur S; Watson MN; Jennings T; Nayak SU; Rawls SM
    Addict Behav; 2021 Mar; 114():106744. PubMed ID: 33291057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.
    Dziedowiec E; Nayak SU; Gruver KS; Jennings T; Tallarida CS; Rawls SM
    Neuroscience; 2018 Aug; 386():214-222. PubMed ID: 29958944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'.
    Raffa RB; Stagliano GW; Ross G; Powell JA; Phillips AG; Ding Z; Rawls SM
    Brain Res; 2008 Feb; 1193():51-6. PubMed ID: 18178175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
    Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous opiates and behavior: 2012.
    Bodnar RJ
    Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model.
    Raffa RB; Baron S; Bhandal JS; Brown T; Song K; Tallarida CS; Rawls SM
    Pharmacol Biochem Behav; 2013 Nov; 112():9-14. PubMed ID: 24084318
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.